Risk of Statin-Induced Hypertransaminasemia-Reference-Cited by-同舟云学术

Risk of Statin-Induced Hypertransaminasemia

Published:2019-06 Issue:2 Volume:3 Page:131-140
ISSN:2542-4548
Container-title:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
language:en
Short-container-title:Mayo Clinic Proceedings: Innovations, Quality & Outcomes

Author:

Villani Rosanna^ORCID,Navarese Eliano Pio,Cavallone Francesco,Kubica Jacek,Bellanti Francesco,Facciorusso Antonio,Vendemiale Gianluigi,Serviddio Gaetano

Funder

Amgen

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial;Griffin;Lancet,2011

2. Diabetes mellitus, fasting glucose, and risk of cause-specific death;Seshasai;N Engl J Med,2011

3. An assessment of statin safety by hepatologists;Cohen;Am J Cardiol,2006

4. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing;Bjornsson;J Hepatol,2012

5. An assessment by the Statin Liver Safety Task Force: 2014 update;Bays;J Clin Lipidol,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rosuvastatin-Induced Myopathy: A Case Series;Cureus;2024-08-05

2. Risk of myopathy and hepatotoxicity in patients with cancer receiving statin therapy: Systematic review of randomized controlled trials;Vascular Medicine;2024-06-11

3. Lipid-lowering therapies for cardiovascular disease prevention and management in primary care;Canadian Family Physician;2023-10

4. Associations between statins and adverse events in secondary prevention of cardiovascular disease: Pairwise, network, and dose-response meta-analyses of 47 randomized controlled trials;Frontiers in Cardiovascular Medicine;2022-08-25

5. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses;BMJ;2021-07-14